Search - tctmd.com

Displaying 21 - 40 of 55

Sort: Relevancy | Date

$Role of Brachytherapy for Refractory ISR in 2018$

Presentation TCT 2018

Role of Brachytherapy for Refractory ISR in 2018

Presenter: Fernando Alfonso, Azeem Latib, Ron Waksman

September 22, 2018

Presentation TCT 2018

Next Generation Drug-Coated Balloons: Limus and Beyond

Presenter: Fernando Alfonso, Azeem Latib, Juan F. Granada

September 22, 2018

Presentation TCT 2018

Are Drug-Coated Balloons Acceptable or Preferred for Stent-Eligible Small Coronary Arteries? Insights From BASKET-SMALL 2 and Other Experiences

Presenter: Fernando Alfonso, Azeem Latib, Bruno Scheller

September 22, 2018

Presentation TCT 2018

POBA, Drug-Coated Balloons, DES and BRS for DES ISR: Advantages, Disadvantages Theory and Evidence

Presenter: Fernando Alfonso, Azeem Latib

September 22, 2018

Presentation TCT 2018

Options for Stent Under-Expansion With ISR: Laser, Stentablation, and More

Presenter: Fernando Alfonso, Azeem Latib, Antonio Colombo

September 22, 2018

Presentation TCT 2018

Case Study: Mechanism and Treatment of Stent Thrombosis

Presenter: Fernando Alfonso, Azeem Latib, Hiram G. Bezerra, Michael J. Cowley, Kevin J. Croce, Lisette Okkels Jensen, Ashish Pershad, Jose M. de la Torre Hernandez

September 22, 2018

Presentation TCT 2018

Is There a Standard Work-Up for Stent Thrombosis? Hematology, Imaging, and More

Presenter: Fernando Alfonso, Azeem Latib, Robert A. Byrne

September 22, 2018

Presentation TCT 2018

Keynote: Why Do Contemporary DES Fail (Early and Late, Restenosis and Thrombosis)?

Presenter: Renu Virmani, Clemens von Birgelen, Michael Joner

September 22, 2018

News Conference News TCT 2018

Radial Access Doubled for Left Main PCI in the UK Between 2007 and 2014

Yael L. Maxwell

September 21, 2018

Presentation TCT 2018

TCT-117: The Burden of Restenosis after Coronary Stent Implantation in the United States: Temporal Trends, Clinical Presentation, Treatment Strategies, and In-Hospital Outcomes

Presenter: Michael A. Kutcher, Tullio Palmerini, Issam D. Moussa

September 21, 2018

Presentation TCT 2018

TCT-39: Functional Assessment of In-stent Restenosis With Quantitative Flow Ratio (QFR). A Comparison With De Novo Coronary Stenoses

Presenter: Javier Escaned, Tim P. Van de Hoef, Catherine Liontou

September 21, 2018

Presentation TCT 2018

Drug-Eluting Stent Thrombosis and Restenosis: Mechanisms, Frequency, and Treatment

Presenter: Joseph P. Carrozza Jr, Jose M. Wiley, Binita Shah

September 21, 2018

Presentation TCT 2018

Treatment of Coronary Drug Eluting Stent Restenosis by a Sirolimus or a Paclitaxel Coated Balloon (B. Braun)

Presenter: Azman Wan Ahmad

September 21, 2018

Presentation TCT 2018

Sirolimus Angioplasty Balloon for In-Stent Restenosis (SABRE) Trial: 3-Year Clinical Follow-Up (Caliber)

Presenter: Juan F. Granada

September 21, 2018

News Conference News ESC 2018

BASKET-SMALL 2: Drug-Coated Balloon Fares Well Against DES for De Novo Small-Vessel Disease

Todd Neale

August 28, 2018

$A Quarter of ‘No Option’ Patients With Refractory Angina End Up Receiving Revascularization Within 2 Years$

News Daily News

A Quarter of ‘No Option’ Patients With Refractory Angina End Up Receiving Revascularization Within 2 Years

Yael L. Maxwell

August 10, 2018

News Daily News

OCT, IVUS Each Boost Long-term Outcomes When Used to Guide PCI, Study Suggests

Todd Neale

July 16, 2018

Podcast TCTMD Talking Points

DARE: A Randomized Trial of a Drug-Eluting Balloon vs a Metallic DES in Patients With Coronary Artery In-Stent Restenosis

June 20, 2018

News Industry News

Medtronic Receives FDA Approval for 200mm & 250mm IN.PACT(TM) Admiral(TM) Drug Coated Balloons

June 18, 2018

News Conference News EuroPCR 2018

DES Slightly Edge Out DCBs in Treatment of In-Stent Restenosis: Meta-analysis

Caitlin E. Cox

May 30, 2018

Advertisement

Role of Brachytherapy for Refractory ISR in 2018

Next Generation Drug-Coated Balloons: Limus and Beyond

Are Drug-Coated Balloons Acceptable or Preferred for Stent-Eligible Small Coronary Arteries? Insights From BASKET-SMALL 2 and Other Experiences

POBA, Drug-Coated Balloons, DES and BRS for DES ISR: Advantages, Disadvantages Theory and Evidence

Options for Stent Under-Expansion With ISR: Laser, Stentablation, and More

Case Study: Mechanism and Treatment of Stent Thrombosis

Is There a Standard Work-Up for Stent Thrombosis? Hematology, Imaging, and More

Keynote: Why Do Contemporary DES Fail (Early and Late, Restenosis and Thrombosis)?

Radial Access Doubled for Left Main PCI in the UK Between 2007 and 2014

TCT-117: The Burden of Restenosis after Coronary Stent Implantation in the United States: Temporal Trends, Clinical Presentation, Treatment Strategies, and In-Hospital Outcomes

TCT-39: Functional Assessment of In-stent Restenosis With Quantitative Flow Ratio (QFR). A Comparison With De Novo Coronary Stenoses

Drug-Eluting Stent Thrombosis and Restenosis: Mechanisms, Frequency, and Treatment

Treatment of Coronary Drug Eluting Stent Restenosis by a Sirolimus or a Paclitaxel Coated Balloon (B. Braun)

Sirolimus Angioplasty Balloon for In-Stent Restenosis (SABRE) Trial: 3-Year Clinical Follow-Up (Caliber)

BASKET-SMALL 2: Drug-Coated Balloon Fares Well Against DES for De Novo Small-Vessel Disease

A Quarter of ‘No Option’ Patients With Refractory Angina End Up Receiving Revascularization Within 2 Years

OCT, IVUS Each Boost Long-term Outcomes When Used to Guide PCI, Study Suggests

DARE: A Randomized Trial of a Drug-Eluting Balloon vs a Metallic DES in Patients With Coronary Artery In-Stent Restenosis

Medtronic Receives FDA Approval for 200mm & 250mm IN.PACT(TM) Admiral(TM) Drug Coated Balloons

DES Slightly Edge Out DCBs in Treatment of In-Stent Restenosis: Meta-analysis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content